Another disappointment: AstraZeneca halts Phase III lung cancer trial for volrustomig
The eVOLVE-Lung02 trial was testing whether volrustomig plus chemotherapy could improve outcomes over the established combination of pembrolizumab…
GSK to seek FDA approval for Jemperli in high-profile cancer use
In what GSK says represents a potential way to transform treatment for patients with certain types of rectal…